BotCl, a chlorotoxin-like peptide isolated from the venom of the scorpion Buthus occitanus tunetanus, has emerged as a promising anticancer agent due to its ability to target ClC-3 chloride channels, which are overexpressed in glioblastoma and breast cancer cells [46,48]. This evidence concerns the gene CLCN3 and breast carcinoma.